Your browser doesn't support javascript.
loading
RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancer.
Elmasry, Manal; Brandl, Lydia; Engel, Jutta; Jung, Andreas; Kirchner, Thomas; Horst, David.
Affiliation
  • Elmasry M; Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Brandl L; Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Engel J; Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Jung A; Munich Cancer Registry (MCR), Department of Medical Information Processing, Biometry and Epidemiology (IBE), Ludwig-Maximilians-Universität München, Munich, Germany.
  • Kirchner T; Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Horst D; German Cancer Consortium (DKTK), Heidelberg, Germany.
J Cancer ; 10(20): 4883-4891, 2019.
Article in En | MEDLINE | ID: mdl-31598160

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Cancer Year: 2019 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Cancer Year: 2019 Document type: Article Affiliation country: Germany